Nova Scotia to Improve Revenue Management Processes with Infor
New "One Person One Record" program prioritizes the modernization of information systems with Infor Healthcare Revenue Cycle Management application
"During our selection process, Infor demonstrated its understanding of the vision and strategic direction of One Person One Record, and how billing systems are part of the overall transformation," said
Nova Scotia Health is the largest provider of health services in
"Modern healthcare organizations understand that their success depends on more than balancing the books every month. It is paramount that they focus on driving efficiencies through improved workflows and communications," said
Learn more about Infor Healthcare: https://www.infor.com/industries/healthcare.
About Infor
Infor is a global leader in business cloud software specialized by industry. We develop complete solutions for our focus industries. Infor's mission-critical enterprise applications and services are designed to deliver sustainable operational advantages with security and faster time to value. Over 60,000 organizations in more than 175 countries rely on Infor's 17,000 employees to help achieve their business goals. As a Koch company, our financial strength, ownership structure, and long-term view empower us to foster enduring, mutually beneficial relationships with our customers. Visit www.infor.com.
Media contact:
Infor
[email protected]
313-246-4268
Copyright ©2023 Infor. All rights reserved. The word and design marks set forth herein are trademarks and/or registered trademarks of Infor and/or related affiliates and subsidiaries. All other trademarks listed herein are the property of their respective owners. www.infor.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nova-scotia-to-improve-revenue-management-processes-with-infor-302042101.html
SOURCE Infor
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trend Micro Announces Up to ¥10 Billion toward Cyber Resilience Initiative to Strengthen Security for Japanese Organizations in the AI Era
- OSE Immunotherapeutics Reports Positive Topline Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung Cancer
- Cabka’s emission reduction targets validated by the Science Based Targets initiative
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share